MVR Cancer Centre & Research Institute

What MVR Cancer Centre & Research Institute does

MVR Cancer Centre & Research Institute operates as a cancer treatment hospital with an attached research function, based on the entity's name and its web domain (mvrcancerhospital.com). The compound identity — "Centre" plus "Research Institute" — implies a dual mandate of clinical oncology service delivery and research activity, potentially including clinical trials, translational research, or basic science work. Such institutions typically serve cancer patients across medical, surgical, and radiation oncology disciplines, and may serve as referral centers for complex cases in their operating geography.

The available input data is extremely limited. The primary source returned only a loading/verification placeholder with no accessible content, and no additional sources were provided. There is no information in the input regarding specific treatment programs, technology platforms, research output, funding sources, ownership structure (private, trust, government-affiliated), bed capacity, geographic footprint, leadership, payer mix, or financial performance. Any deeper characterization of the business model, technology stack, or competitive positioning is therefore not supportable from the supplied evidence and would constitute fabrication. The description above is limited strictly to what the name and domain establish as fact.

Name

MVR Cancer Centre & Research Institute

Website

https://mvrcancerhospital.com

Company type

Private

Founded year

2017

Headcount range

501–1,000 employees

Short description

MVR Cancer Centre & Research Institute is a cancer treatment hospital and research institution. The organization combines clinical oncology services with research activities, serving cancer patients in its operating region.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Medical Oncology (HLAKAFAB)

Keywords

• Cancer treatment services
• Oncology care
• Cancer research
• Radiation oncology
• Medical oncology

Headquarters

HQ city

Kozhikode

HQ country

India

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Core offering

MVR Cancer Centre & Research Institute operates as a dedicated cancer hospital and research institute, inferred from its institutional name and the associated domain mvrcancerhospital.com. It is positioned to deliver oncology diagnosis, treatment, and research services to patients. Specific clinical offerings and programs are not evidenced in the available source data, which consists of only a loading/verification message on the website.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Apollo Cancer Centre: Cancer care arm of Apollo Hospitals, India's largest hospital chain. Comparable oncology service offering within a broader multi-specialty network; competes for the same specialty referrals.
• Max Institute of Cancer Care: Oncology service line of Max Healthcare, a major hospital chain. Comparable specialty oncology services embedded in a multi-specialty platform; competes for the same oncologists and complex cancer cases.
• Fortis Memorial Research Institute: Flagship hospital of Fortis Healthcare with significant oncology capability. Comparable tertiary oncology offerings including medical, surgical, and radiation oncology within a multi-specialty platform.
• Medanta Cancer Institute: Oncology department of Medanta - The Medicity, a leading multi-specialty hospital. Comparable specialty oncology offering with research activity; competes in the same tertiary referral market.

Direct peers

• Cytecare Cancer Hospital: Standalone specialty cancer hospital focused on oncology. Closely comparable as a dedicated single-site cancer center with research emphasis and tertiary case mix.
• Tata Memorial Hospital: India's premier publicly-funded cancer hospital and research center. Directly comparable as a dedicated cancer hospital with an attached research mandate; the benchmark specialty oncology institution in India.
• Healthcare Global Enterprises (HCG): Largest dedicated cancer care network in India operating multiple cancer centers. Closest direct peer in specialty oncology combining clinical oncology with research and trial activity.
• Rajiv Gandhi Cancer Institute & Research Centre: Standalone non-profit cancer hospital and research center in Delhi NCR. Closely comparable in scale, mandate, and naming convention; directly competes for oncology patients in northern India.
• American Oncology Institute: Network of dedicated cancer hospitals in India operating with US oncology partnerships. Comparable specialty oncology model with research and clinical trial capability.
• Kidwai Memorial Institute of Oncology: Public regional cancer center and research institute in Karnataka, India. Directly comparable as a publicly-supported cancer hospital with attached research mandate.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights2 records

Customer concentration

• Xx.com/mvrcancercentre
• Facebookfacebook.com/mvrcancerhospital
• LinkedInlinkedin.com/company/mvrcancercentre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MVR Cancer Centre & Research Institute